Retinitis pigmentosa is an inherited condition that gradually destroys the light-sensing cells of the retina, usually starting with night vision and side vision, while macular degeneration is an age-related disease that damages the center of the retina and mainly affects sharp central vision after about age 50. Neither can be cured today. Treatment for the common wet form of macular degeneration is well established, options for retinitis pigmentosa are more limited, and newer approaches such as gene therapy and stem cell treatment are still being studied.
Retinitis pigmentosa: inherited, often begins in childhood or young adulthood, and causes night blindness and shrinking side vision
Macular degeneration: linked to aging, and causes blurred or distorted central vision while side vision is usually kept
Diagnosis matters: a retina specialist can tell them apart with an eye examination and specialized scans, and early detection helps protect remaining vision
Retinitis Pigmentosa vs Macular Degeneration: Quick Comparison
Both conditions damage the retina, the light-sensing layer at the back of the eye, so both can lead to vision loss. The difference is which part of the retina is affected and why. Retinitis pigmentosa is a group of inherited conditions that mainly affects night and side vision. Macular degeneration is linked to aging and mainly affects the sharp central vision used for reading and recognizing faces.
How the Vision Loss Differs
More typical of retinitis pigmentosa
Trouble seeing in dim light or at night, often noticed first
Side (peripheral) vision slowly narrows, like looking through a tube
Slow adjustment when moving from bright to dark places
Often starts in childhood, the teens, or young adulthood
Central vision is usually kept until late in the disease
More typical of macular degeneration
Blurred or dim vision right in the center of what you are looking at
Straight lines, such as door frames, look wavy or bent
A dark or empty patch in the middle of the vision
Usually begins after about age 50
Side vision is usually kept, so total blindness is rare
Side-by-Side Comparison
Feature
Retinitis PigmentosaInherited
Macular DegenerationAge-related
Main cause
Gene changes that cause the light-sensing cells (rods and then cones) to slowly die
Aging changes in the macula, shaped by genes, smoking, and other risk factors
Usual age at onset
Often childhood to young adulthood, though it can start later
Usually after about 50, and more common with each decade
Part of the retina affected
Mainly the outer retina first, which handles night and side vision
The macula, the small central area that gives sharp detail
First symptom
Night blindness
Blurred or distorted central vision
Side vision
Gradually lost
Usually preserved
Central vision
Usually preserved until later stages
Lost first
Both eyes?
Yes, and usually in a similar way
Often both, but one eye can be worse, especially in the wet type
Runs in families?
Yes, it is inherited, though some people have no known family history
Family history raises the risk, but it is not inherited in a simple pattern
Speed of progression
Usually slow, over many years, but varies widely
Dry type is usually slow, while wet type can worsen within weeks to months
Main current treatment
No cure. Care focuses on protecting remaining sight and low-vision support, and one rare gene type has an approved gene therapy
Wet type: eye injections to stop abnormal vessels. Dry type: lifestyle changes and certain vitamin supplements to slow progression
Other eye problems can look similar. Glaucoma, cataract, diabetic eye disease, and retinal detachment can also cause blurred or lost vision, and cataract is common in people with retinitis pigmentosa. This is why symptoms need to be checked by an eye specialist before anyone decides what the cause is.
See an eye doctor urgently if your vision suddenly becomes distorted, a new dark spot appears in the center, or you notice a sudden shower of floaters, flashes of light, or a curtain over part of your vision. Wet macular degeneration and retinal detachment can damage sight within days, and early treatment protects what you have.
This comparison is general information. Symptoms vary between people and cannot replace a full eye examination.
What Is Retinitis Pigmentosa?
Retinitis pigmentosa (RP) is a group of inherited eye diseases in which the light-sensing cells of the retina slowly break down over time. The retina has two main kinds of these cells. Rods handle night vision and side vision, and cones handle sharp central vision and color. In RP the rods usually fail first, which is why night blindness and loss of side vision come early. It affects roughly 1 in 4,000 people, and it affects both eyes.
What Causes Retinitis Pigmentosa?
RP is caused by changes (mutations) in genes that keep the retina's cells healthy. Dozens of genes have been linked to it, and the way it passes through a family depends on which gene is involved.
Inheritance pattern
What it means
Autosomal recessive
A child is affected when they inherit a faulty copy of the gene from both parents, who usually have normal vision. It is more likely when parents are related.
Autosomal dominant
One faulty copy from one parent is enough, so the condition often appears in several generations of a family.
X-linked
The gene is on the X chromosome, so it mostly affects males, while female carriers may have milder signs.
No known family history
Some people are the first in their family to be diagnosed, because the gene change is hidden in the family or is new.
Common Symptoms of Retinitis Pigmentosa
Night blindness: difficulty seeing in dim light, often the first sign, and often noticed in childhood or the teens
Tunnel vision: side vision shrinks slowly, so you bump into objects or miss things at the edges
Slow adjustment to darkness: it takes much longer for your eyes to adapt when you move from light to dark places
Glare and light sensitivity: bright light or oncoming headlights can be uncomfortable or blinding
Later changes: reduced color vision and, in advanced disease, loss of central vision
How Retinitis Pigmentosa Progresses
Early stage. Night vision declines. Daytime vision is usually good, and many people adapt without realizing the cause.
Middle stage. Side vision narrows, making driving, walking in crowds, and finding things around the room harder.
Advanced stage. The field of vision can become very small, and central vision may begin to fade, making reading and recognizing faces difficult.
The pace varies a great deal. Some people lose vision noticeably over a decade or two, while others keep useful sight into later life. Even people who are legally blind often keep some vision. Regular eye checks help track how fast your own condition is changing.
Conditions That Can Occur With Retinitis Pigmentosa
Usher syndrome
RP together with hearing loss, and one of the more common causes of combined vision and hearing loss
Cataract
Clouding of the lens develops earlier in many people with RP, and cataract surgery can help
Macular swelling
Fluid can collect in the central retina, which can blur vision and may be treated
Living Well With Retinitis Pigmentosa
Regular specialist care: see a retina specialist regularly to track changes and treat problems such as cataract or macular swelling
Protect your eyes: wear sunglasses that block ultraviolet light outdoors
Low-vision support: magnifiers, good lighting, screen-reading tools, and mobility training can help you stay independent
Genetic counseling: genetic testing can identify the gene involved, help with family planning, and show whether a specific therapy might apply
Family screening: brothers, sisters, and children of someone with RP should have an eye examination
Do not start high-dose vitamins or supplements on your own. Some vitamins, especially vitamin A, can be harmful in large amounts, particularly in pregnancy. Only take them if your retina specialist advises it and monitors you.
Looking for newer options? There is no cure yet, but research into gene therapy and cell-based approaches is active. You can read what is currently being studied in stem cell research for retinitis pigmentosa, which is still investigational, and we cover the wider picture later in this article.
What Is Macular Degeneration?
Macular degeneration, usually called age-related macular degeneration (AMD), is a common eye disease that damages the macula, the small central part of the retina that gives you sharp, detailed vision. It is a leading cause of central vision loss in people over 50. Because it spares the edges of the retina, side vision is usually kept, and AMD rarely causes complete blindness. It is painless, which is why many people do not notice it until vision has already changed.
Dry vs Wet Macular Degeneration
Dry AMD (the more common type)
Makes up most cases, roughly 85 to 90 percent
The macula slowly thins, and small yellow deposits called drusen build up under the retina
Vision loss is usually gradual, over years
In its late stage, patches of retinal cells die (called geographic atrophy)
It can sometimes turn into the wet type
Wet AMD (less common, more serious)
Makes up the smaller share of cases, roughly 10 to 15 percent
Abnormal, fragile blood vessels grow under the macula and leak fluid or blood
Vision can worsen quickly, over weeks to months
Causes most of the severe vision loss from AMD
Responds best when treated early
What Causes Macular Degeneration?
There is no single cause. AMD develops from a mix of aging and other risk factors:
Age
The strongest risk factor. The chance rises steadily after 50 and is highest after 75.
Smoking
The biggest risk you can change. Smokers are much more likely to develop AMD and to lose vision faster.
Family history and genes
Having a parent or sibling with AMD raises your risk, as certain genes make the macula more vulnerable.
Heart and blood vessel health
High blood pressure, high cholesterol, and heart disease are linked to a higher risk.
Diet and weight
A diet low in leafy greens and fish, and being overweight, are associated with greater risk.
Ethnicity
AMD is more common in people of European descent, though it affects people of all backgrounds.
Symptoms of Macular Degeneration
Blurred central vision: text or faces look smudged, even with the right glasses
Wavy or bent lines: straight lines, such as door frames or text lines, look distorted
A dark or empty spot: a blank patch appears in the center of your vision
Trouble with detail: reading, recognizing faces, and close work become harder, and you need brighter light
No pain: AMD does not hurt, and early disease often causes no symptoms at all
Stages of Macular Degeneration
Early AMD. Small drusen are seen during an eye examination. There are usually no symptoms and vision is normal.
Intermediate AMD. Larger drusen form, and some people notice mild blurring or need more light for reading.
Late AMD. Central vision is clearly affected, either from the slow loss of retinal cells (dry type) or from leaking blood vessels (wet type).
A Simple Home Check: the Amsler Grid
An Amsler grid is a small square of straight lines with a dot in the middle, used to spot early changes. Hold it at reading distance in good light, wear your reading glasses, cover one eye, and look at the dot.
What to look for: if any lines look wavy, blurry, or missing, or if part of the grid looks dark, contact an eye doctor promptly. The grid is only a quick check between visits and cannot replace a full eye examination.
Can You Lower Your Risk or Slow It Down?
Do not smoke: quitting is the single most effective step
Eat well: include leafy green vegetables, colorful fruit and vegetables, and fish
Look after your heart: exercise regularly and keep blood pressure, cholesterol, and weight in a healthy range
Protect your eyes from the sun: wear sunglasses that block ultraviolet light
Have regular eye examinations: after 50, a dilated eye exam can find AMD before it causes symptoms
New distortion or a new dark spot needs an eye exam within days, not weeks. Wet AMD can damage vision quickly, and treatment works best when it starts early.
Looking at newer options? Current treatment focuses on slowing the disease and, in wet AMD, stopping the leaking vessels. To read about cell-based research for this condition, see our page on stem cell therapy for macular degeneration, and note that these approaches are still being studied.
How Eye Doctors Tell Retinitis Pigmentosa from Macular Degeneration
Eye doctors tell the two conditions apart with a dilated eye examination and a set of specialized scans and tests. The pattern of vision loss you describe is the first clue, but the tests show exactly which part of the retina is damaged and how. No single symptom or home check can confirm either condition.
Which Specialist Should You See?
Ophthalmologist
A medical eye doctor who does the first examination, and who can diagnose and treat many eye conditions.
Retina specialist
An ophthalmologist trained in diseases of the retina. This is the right specialist for both RP and macular degeneration.
Genetic counselor
Helps you understand genetic test results for inherited conditions such as RP, and what they mean for your family.
How the Diagnosis Is Made
Your history. The doctor asks when symptoms began, whether you struggle most in the dark or with reading, and whether anyone in your family has eye disease.
Vision tests. Your sharpness of vision, color vision, and eye pressure are checked.
Dilated examination. Drops widen your pupils so the doctor can look at the retina directly for the typical changes of each condition.
Scans and special tests. Imaging and tests of retinal function show the damage in detail and help separate one condition from the other.
Genetic testing, when relevant. If retinitis pigmentosa is suspected, a blood or saliva test can look for the gene involved.
Common Tests and What They Show
Test
What it checks
Typical in retinitis pigmentosa
Typical in macular degeneration
Dilated retinal examination
The look of the retina and blood vessels
Dark, spidery pigment patches in the outer retina and thin blood vessels
Drusen and pigment changes in the macula, with bleeding or fluid in wet AMD
OCT scan
A cross-section image of the retinal layers
Thinning of the outer retinal layers, and sometimes fluid in the macula
Drusen, thinning or fluid and swelling under the macula
Visual field test
How much of your side and central vision you can see
A narrowed field, like tunnel vision
A blind or blurred patch in the center
Electroretinogram (ERG)
The electrical response of the rods and cones to light
Reduced or absent rod response, often early
Not usually needed, and rarely shows the same pattern
Fundus autofluorescence
Healthy and unhealthy retinal cells, shown by their natural glow
A ring pattern around the center in many people
Dark patches where cells have died (geographic atrophy)
Fluorescein angiography or OCT angiography
Blood flow and leaking vessels, using dye or special imaging
Used when swelling is suspected
Shows leaking abnormal vessels in wet AMD
Genetic testing
Gene changes that cause inherited retinal disease
Often recommended, to identify the gene and guide family counseling
Not routinely done
Why a confirmed diagnosis matters. The right care depends on knowing which condition you have, and for retinitis pigmentosa, which gene is involved. Treatments and clinical trials are often limited to specific types, so a clear diagnosis is the foundation for every decision that follows.
What to Bring to Your Appointment
A symptom note: when it started, what you struggle with most, and whether it is in one eye or both
Earlier eye reports and scans: OCT images, visual field results, and photographs, so changes over time can be compared
Family history: relatives with vision loss, blindness, or hearing loss
Your medicines and health conditions: including diabetes, blood pressure, and any supplements you take
A companion: dilating drops blur your vision for a few hours, so you should not drive yourself home
Want another specialist to review your results? If your diagnosis is unclear or you have been offered a treatment you are unsure about, you can have your eye reports reviewed by retina specialists in India and compare their view with the advice you have already received.
Be cautious of any clinic that offers a treatment without a full diagnosis. A reliable eye center examines you, runs the relevant scans, and explains your condition before recommending anything. Skipping these steps is a warning sign.
Current Treatments for Retinitis Pigmentosa and Macular Degeneration
Neither condition has a cure, but some treatments are well established. For wet macular degeneration, eye injections can stop the damage and often save vision. For dry macular degeneration, certain vitamins and healthy habits can slow progression. For retinitis pigmentosa, care mainly protects remaining sight and supports daily life, with a gene therapy available for one rare type. The table below shows what is proven today.
Established Treatments at a Glance
Condition
Established option
What it does
Wet macular degeneration
Anti-VEGF eye injections
Stops abnormal vessels from leaking and growing, which stabilizes vision in most people and improves it in some
Intermediate dry macular degeneration
A specific vitamin and mineral formula (AREDS2), plus lifestyle changes
Lowers the chance of progressing to the advanced stage, but does not restore vision
Slow the growth of the damaged area, but do not bring back lost vision
Retinitis pigmentosa, one rare gene type
Gene therapy for RPE65 mutations
Improves vision in people who have this specific gene change, which is a small minority of patients
Retinitis pigmentosa, most people
Supportive care: treating complications, protecting the eyes, and low-vision rehabilitation
Preserves remaining sight and independence, but does not stop the underlying disease
Treating Wet Macular Degeneration
Anti-VEGF injections are the standard treatment. VEGF is a protein that makes abnormal blood vessels grow, and these medicines block it. They have to be repeated, often every one to three months, and the schedule is adjusted to how your eye responds.
Preparation. Your eye is cleaned and numbed with drops or a small injection, so you feel little or no pain.
The injection. A very fine needle places a small amount of medicine into the gel inside the eye, which takes only a minute or two.
Afterward. You may feel mild scratchiness or see small floaters for a day, and you can usually go home straight away.
Monitoring. Regular scans show how well it is working and when the next injection is due.
Do not skip injections or follow-up visits. Stopping treatment early can let the leaking return and vision fall again. Call your eye doctor at once if, after an injection, you have increasing pain, redness, or a drop in vision.
Slowing Dry Macular Degeneration
What can help
The AREDS2 supplement formula, for people with intermediate AMD or advanced AMD in one eye, as advised by an eye doctor
Quitting smoking
A diet rich in leafy greens and fish
Controlling blood pressure and cholesterol
Regular scans and Amsler grid checks to catch a switch to the wet type
What to keep in mind
The supplement formula is not meant for everyone, and is not proven to prevent AMD in healthy eyes
Newer injections for geographic atrophy slow growth only, and are not available everywhere
Over-the-counter eye vitamins vary, so ask which formula matches the studies
Nothing available today regrows lost retinal cells
Care for Retinitis Pigmentosa
Gene therapy for one rare type: a one-time treatment placed under the retina is approved for people who carry changes in both copies of the RPE65 gene. Genetic testing shows whether you qualify, and availability varies by country.
Treating complications: cataract surgery can clear vision clouded by a cataract, and swelling in the central retina can be treated with eye drops, tablets, or injections
Vitamin A, only under supervision: some specialists suggest vitamin A for certain adults after weighing the evidence, which is mixed. It can be harmful in the wrong dose and is avoided in pregnancy, and high-dose vitamin E is generally not advised.
Eye protection: sunglasses that block ultraviolet light, and avoiding bright glare
Genetic counseling and support: understanding the inheritance in your family and getting emotional and practical support
Low-Vision Support for Both Conditions
When vision cannot be fully restored, low-vision rehabilitation helps you use the sight you have. It can make a big difference to independence and quality of life.
Optical aids: magnifiers, telescopic glasses, and electronic readers
Lighting and contrast: brighter task lighting, high-contrast labels, and dark mode on screens
Training: orientation and mobility training, and learning to use screen readers and voice assistants
Ask what is available where you live. Approvals, costs, and access to injections and newer therapies differ from one country and hospital to another. Your retina specialist can tell you which proven options you can use now.
Be cautious of claims that any supplement, device, or injection will restore vision in retinitis pigmentosa or reverse macular degeneration. If a therapy is not among the established options above, ask whether it is part of a regulated clinical trial and who oversees it.
This section is general information. Treatment decisions should be made with your own retina specialist, who can advise on what is approved and suitable in your case.
Emerging Treatments for Retinitis Pigmentosa and Macular Degeneration
Several new approaches are being tested, including more gene therapies, cell-based treatments, retinal implants, and drugs that protect surviving cells, but most are still in clinical trials and are not yet proven or approved. The research is real and some results are encouraging, but a treatment being studied is not the same as a treatment that works. This section explains where each approach stands, so you can read the news with confidence.
Where Each Approach Stands
Approach
What it aims to do
Current status
What to know
Gene therapy for other genes
Replace or repair a faulty gene so retinal cells work normally
Clinical trials
Approved for one RP gene type only. Others are being tested, with mixed results so far.
Optogenetics
Make surviving retinal cells sensitive to light, whatever gene is faulty
Early clinical trials
Aimed at advanced RP. Early results are promising but small.
Gene therapy for wet AMD
Help the eye make its own anti-VEGF medicine, to reduce repeat injections
Clinical trials
Regular injections remain the standard treatment.
Cell replacement
Replace damaged retinal cells with new, lab-grown cells
Early clinical trials
Studied mainly for AMD and RP. Safety is being tested, and benefit is not yet proven.
Retinal implants
Use an electronic device to send light signals to the brain
Limited use and trials
Can help some people with very advanced disease detect light, shapes, or letters, but the sight gained is limited.
Neuroprotective drugs
Protect surviving retinal cells from dying
Clinical trials
Several candidates are being tested, and none is yet a standard treatment.
Stem Cell Treatment: What Is Proven and What Is Not
Stem cells are of particular interest because they can turn into other cell types, and researchers hope they can one day replace the retinal cells lost in these diseases. In the laboratory and in carefully run trials, the work is promising. But there is an important difference between regulated research and treatments sold to patients.
What research shows so far
Lab-grown retinal cells can be made and transplanted in controlled studies
Early trials mainly test safety and whether the cells survive
Any vision benefit so far is small, uncertain, or limited to certain patients
Results from one type of cell or one disease do not apply to others
What is not established
A stem cell injection that reliably restores vision in RP or macular degeneration
The long-term safety of unregulated eye injections
Standard doses, cell types, or methods that work across patients
Claims based only on patient testimonials
Serious harm has been reported. Medical journals and regulators have documented cases of severe vision loss, including blindness, after unregulated stem cell injections into the eye. If you are considering any cell-based treatment, it should be part of a registered clinical trial with ethics approval, not a service sold by a clinic.
Want to see how this research is described? Our pages explain the cell-based approaches being studied for retinitis pigmentosa and for macular degeneration, including what is still investigational. Please read them alongside this article and discuss any option with your retina specialist first.
How to Read News About an Eye "Breakthrough"
Was it done in people, or only in animals? Results in mice or cells in a dish often do not carry over to humans
What phase is the trial? Early trials test safety in a few people, and only larger later trials show whether a treatment works
How many people, and for how long? A handful of patients followed for a few months says little about lasting benefit
Was it published and reviewed? Look for results in a peer-reviewed medical journal, not only a press release or a clinic's website
Does it apply to your condition? A therapy tested for one gene type or one stage may not apply to yours
How to Find a Genuine Clinical Trial
Legitimate trials are registered in public databases. You can search by your condition and country on ClinicalTrials.gov and, for studies in India, the Clinical Trials Registry of India. Your retina specialist or a genetic counselor can also tell you which trials match your diagnosis and, for retinitis pigmentosa, your gene. In a real trial, you are usually not charged for the experimental treatment itself.
Getting an Eye Evaluation in India as an International Patient
International patients travel to India for a retinal evaluation, a confirmed diagnosis, genetic testing, and established treatments such as injections for wet macular degeneration, cataract surgery, and low-vision rehabilitation. The most useful first step is a thorough examination at a reputable retina center. What you should be careful about is any clinic that offers an unproven treatment instead of, or before, a proper diagnosis.
What to Send Before You Travel
A retina specialist can review your earlier tests in advance and tell you which new tests are really needed, so you do not repeat everything.
Retinal scans: OCT scans, fundus photographs, and fundus autofluorescence images, as image files as well as printed reports where possible
Function tests: visual field results and electroretinogram (ERG) reports, if you have had them
Genetic test results: the full report, not only a summary, for retinitis pigmentosa
Treatment history: any injections, laser, surgery, or supplements, with dates, and the name of any medicine used
Family history and general health: relatives with vision or hearing loss, plus diabetes, blood pressure, medicines, and allergies
How Long Should You Plan to Stay?
Purpose of the visit
Typical time to plan in India
What to know
Evaluation and confirmed diagnosis
Around 2 to 4 days
Examination, scans, and function tests, with genetic test results often arriving later
Low-vision assessment
Around 1 to 2 days
Testing for the aids and training that suit you
Cataract surgery
Often around 1 week
Surgery, then a check-up the next day and a review a few days later
Eye injections for wet AMD
A few days for the first treatment
Injections must be repeated regularly, so plan the ongoing schedule with a doctor near your home
These are general planning ranges, and the specialist confirms the actual plan. Wet macular degeneration needs ongoing, closely timed treatment, so travelling for repeat injections is rarely practical. A trip is better used for an expert opinion and a clear plan that your local doctor can then carry out.
Questions to Ask Any Clinic Offering a Treatment
Which tests will you do to confirm my diagnosis before recommending anything?
Is this treatment approved for my condition, or is it experimental?
If it is experimental, what is the trial registration number and which ethics committee approved it?
Who will perform the procedure, and are they a trained retina specialist?
Where is the published evidence, and what were the results for patients like me?
What are the risks, and what happens if something goes wrong?
How will my follow-up care be arranged after I go home?
Good Signs and Warning Signs
Signs of a reliable center
Examines you and runs the relevant scans before advising
Explains clearly what is proven and what is experimental
Has retina specialists and accredited facilities
Is open about risks, limits, and realistic outcomes
Offers a written plan and shares your records
Warning signs
Promises to restore or cure vision, or guarantees results
Recommends treatment without examining you or reviewing scans
Charges patients for an experimental treatment outside a registered trial
Offers the same injection for every eye condition
Relies on testimonials, with no medical evidence or published data
Travel with a companion. If your vision is limited, or if your eyes will be dilated for tests, travel with someone who can help you at airports, in unfamiliar places, and on the way home. Ask in advance about assistance services at the airport.
Quick answers to the questions people ask most about retinitis pigmentosa and macular degeneration.
Can retinitis pigmentosa turn into macular degeneration, or can you have both?
Retinitis pigmentosa does not turn into macular degeneration, because they are different diseases with different causes. In advanced retinitis pigmentosa the central retina can also be damaged, but that is part of the same disease. It is possible, though uncommon, for an older person with retinitis pigmentosa to also develop age-related macular degeneration. An eye specialist can tell which condition is responsible for which change.
Which condition is more likely to cause blindness?
Both can cause serious vision loss, but complete blindness is uncommon in either. Macular degeneration usually spares side vision, so people keep their independence for getting around even when central vision is lost. Retinitis pigmentosa can shrink the visual field to a very small area over many years, and it can progress to severe vision loss in advanced stages. The pace varies a great deal between people.
Is retinitis pigmentosa curable?
There is currently no cure. A gene therapy is approved for people with changes in both copies of one specific gene (RPE65), which is a small minority of patients. For most people, care focuses on treating complications such as cataract, protecting the eyes, low-vision support, and genetic counseling, while research continues into new treatments.
Is macular degeneration hereditary?
Genes play a part, so having a parent or sibling with macular degeneration raises your risk. But it is not inherited in a simple, predictable pattern the way retinitis pigmentosa is. Smoking, age, and other lifestyle factors also matter a great deal, which means some of the risk is within your control.
Can supplements or vitamins reverse either condition?
No supplement can reverse either condition or restore lost vision. A specific vitamin and mineral formula (AREDS2) can slow progression in people with intermediate macular degeneration, but it is not for everyone and does not bring vision back. For retinitis pigmentosa, vitamin A is sometimes suggested for certain adults under specialist supervision, the evidence is mixed, and it can be harmful in the wrong dose. Do not start high-dose supplements without your eye doctor's advice.
Does stem cell therapy work for retinitis pigmentosa or macular degeneration?
Stem cell treatment for these conditions is still experimental. Early trials are testing whether lab-grown cells can be transplanted safely, and any benefit to vision has not been proven. Serious harm, including blindness, has been reported after unregulated stem cell injections into the eye, so any cell-based treatment should only be considered within a registered clinical trial. You can read more in our pages on retinitis pigmentosa stem cell information and macular degeneration stem cell information.
How often should I have my eyes checked?
It depends on your condition and your specialist's advice. People over 50 benefit from a regular dilated eye examination to find early macular degeneration. If you have been diagnosed, your retina specialist will set a schedule, which may be every few months for wet macular degeneration and often every six to twelve months for retinitis pigmentosa. Between visits, check for new distortion or dark spots and report any sudden change straight away.
Can I still drive with retinitis pigmentosa or macular degeneration?
It depends on how much vision you have. Many people with retinitis pigmentosa find night driving unsafe early on, and a narrowed visual field can make driving risky. Central vision loss from macular degeneration makes reading signs and judging detail harder. Driving rules differ by country, and your eye specialist can test your visual acuity and field and advise what is safe for you.
Is it worth travelling to India for an eye evaluation?
It can be useful for a confirmed diagnosis, genetic testing, or an expert second opinion, especially when your diagnosis is unclear. Treatments that need regular repeat visits, such as injections for wet macular degeneration, are better arranged close to home. Before deciding, you can get your eye reports reviewed by specialists in India and see whether travel is really needed.
Medical disclaimer: this article is for general information and does not replace advice from your own eye specialist. If you notice a sudden change in your vision, see an eye doctor urgently.
Eye Health Guide
